Creative Medical Technology

Penny Stocks Biotech Stocks Healthcare Stocks

$2.24

+0.03 (+1.36%)

As of May 16, 2:34 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +1,390.6% upside

Low Target $22.85

Average Target $33.39

High Target $43.53

Current Price $2.24

Current
$2.24

Target
$33.39

$22.85 $33.39 avg $43.53

Scenario Analysis

Bear Case

$22.85

920.1%

Low target

Base Case

$33.39

+1,390.6%

Avg target

Bull Case

$43.53

+1,843.3%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$6.25

-64.2% from high

52-Week Low

$1.50

+48.9% from low

Target vs 52W High

$33.39

+434.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%